Royalty Pharma revenue and financials
$56.44Change from previous close: −0.39%Absolute change: −$0.22
In the fiscal year ended December 2025, Royalty Pharma reported revenue of $2.38B (+5.06% year over year). Net income was $770.95M, a net margin of 32.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +5.06%
- 2025 vs 2024
- Net income growth
- −10.25%
- 2025 vs 2024
- Net margin
- 32.4%
- 2024: 37.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 19,820 | 19,815 | 19,621 | 19,347 | 18,323 | 17,608 | 18,223 | 18,042 | 17,657 | 16,131 | 16,382 | 15,856 |
| Current assets | 1,765 | 1,426 | 1,528 | 1,850 | 1,520 | 1,843 | 1,802 | 1,794 | 2,579 | 1,560 | 1,274 | 1,729 |
| Cash and equivalents | 812 | 586 | 619 | 939 | 632 | 1,088 | 929 | 950 | 1,765 | 843 | 477 | 936 |
| Short-term investments | 25.0 | 21.9 | 18.8 | 16.1 | 13.2 | 12.1 | 58.2 | 48.5 | 38.5 | 29.0 | 18.3 | 5.3 |
| Receivables | 921 | 807 | 884 | 889 | 871 | 740 | 811 | 791 | 774 | 683 | 761 | 780 |
| Net property, plant and equipment | — | 18.3 | 19.1 | 19.8 | 20.6 | — | — | — | — | — | — | — |
| Goodwill | 924 | 925 | 925 | 925 | 925 | — | — | — | — | — | — | — |
| Other intangible assets | — | — | — | 5.3 | 5.3 | 5.3 | 5.3 | 5.3 | 5.3 | — | 1.8 | 16.3 |
| Long-term investments | 876 | 846 | 880 | 723 | 658 | 696 | 1,260 | 1,237 | 1,160 | 1,101 | 1,012 | 876 |
| Current liabilities | 631 | 536 | 636 | 531 | 1,207 | 1,183 | 1,254 | 1,168 | 276 | 125 | 161 | 128 |
| Accounts payable | 35.6 | 25.5 | 19.4 | 41.4 | 20.2 | 37.6 | 13.4 | 22.1 | 23.4 | 11.6 | 15.2 | 13.6 |
| Long-term debt | 8,582 | 8,576 | 8,571 | 8,566 | 7,003 | 6,619 | 6,615 | 6,610 | 7,602 | 6,139 | 6,135 | 6,131 |
| Total debt | 8,962 | 8,956 | 8,951 | 8,946 | 8,002 | — | — | — | — | — | — | — |
| Total liabilities | 10,034 | 9,879 | 9,906 | 9,726 | 8,820 | 7,820 | 7,880 | 7,784 | 7,905 | 6,267 | 6,298 | 6,270 |
| Total equity (incl. minority) | 9,786 | 9,937 | 9,715 | 9,621 | 9,503 | 9,789 | 10,342 | 10,258 | 9,752 | 9,864 | 10,084 | 9,585 |
| Retained earnings | 2,459 | 2,507 | 2,356 | 2,304 | 2,223 | 2,481 | 2,846 | 2,765 | 2,378 | 2,427 | 2,518 | 2,135 |
| Minority interest | 2,953 | 3,048 | 3,238 | 3,207 | 3,155 | 3,100 | 3,396 | 3,389 | 3,276 | 3,364 | 3,558 | 3,446 |